The Stillbirth Clinical Study Group was set up in March 2011 and is chaired by Professor Gordon Smith, Head of Department of Obstetrics and Gynaecology at Cambridge University. The executive committee currently comprises obstetrics, pathology, epidemiology and public health as well as input from statisticians and modelling experts. The Stillbirth CSG is sponsored by Sands, the stillbirth and neonatal death charity, and has Sands and parental representation.
Stillbirth affects one in 200 babies after 24 weeks gestation and is one of the most common serious complication in pregnancy, devastating the lives of around 4,000 families every year in the UK. The majority (~90%) of stillborn babies do not have a lethal congenital abnormality and the majority of mothers experiencing stillbirth do not have a major pre-existing medical condition. The current methods for screening low-risk pregnant women are virtually unchanged in recent decades and are crude in comparison with other screening tools used for Down’s syndrome for example. There is a need therefore to improve the detection of babies at risk of stillbirth coupled with safe and effective intervention.
The Stillbirth CSG meets approximately every six months. The last meeting was held on the 3rd November 2016 at which the May minutes were confirmed. Minutes are available.
The remit of the Stillbirth CSG is:
- To identify priorities for research into stillbirth
- To propose and develop well designed studies including trials
- To consider studies proposed by members of the group and others
- To provide specific advice to investigators
- To ensure stakeholder involvement
Given the limitations of funding in this area, the CSG is hoping to unify research priorities and proposals to maximise their effectiveness and would welcome collaboration from researchers interested in this area. For specific inquiries please contact Professor Gordon Smith, firstname.lastname@example.org or Janet Scott at email@example.com